54 related articles for article (PubMed ID: 8343222)
21. Analysis of the BRCA1 and BRCA2 genes in sporadic meningiomas.
Kirsch M; Zhu JJ; Black PM
Genes Chromosomes Cancer; 1997 Sep; 20(1):53-9. PubMed ID: 9290954
[TBL] [Abstract][Full Text] [Related]
22. Alteration and enhanced expression of the c-myc oncogene in human colorectal carcinomas.
Matsumura T; Dohi K; Takanashi A; Ito H; Tahara E
Pathol Res Pract; 1990 Apr; 186(2):205-11. PubMed ID: 2188234
[TBL] [Abstract][Full Text] [Related]
23. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
24. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas.
Tabernero MD; Espinosa AB; Maillo A; Rebelo O; Vera JF; Sayagues JM; Merino M; Diaz P; Sousa P; Orfao A
Oncologist; 2007 Oct; 12(10):1225-36. PubMed ID: 17962616
[TBL] [Abstract][Full Text] [Related]
25. Clonal analysis of human meningiomas and schwannomas.
Jacoby LB; Pulaski K; Rouleau GA; Martuza RL
Cancer Res; 1990 Nov; 50(21):6783-6. PubMed ID: 2208143
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
28. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
[TBL] [Abstract][Full Text] [Related]
29. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
30. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
[TBL] [Abstract][Full Text] [Related]
31. Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10.
Asirvatham JR; Pai R; Chacko G; Nehru AG; John J; Chacko AG; Muliyil J
Neurol India; 2013; 61(2):138-43. PubMed ID: 23644312
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical study of MRP5 expression in meningiomas.
Alexiou GA; Goussia A; Ntoulia A; Zagorianakou P; Malamou-Mitsi V; Voulgaris S; Kyritsis AP
Cancer Chemother Pharmacol; 2013 Mar; 71(3):825-8. PubMed ID: 23271324
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
34. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
35. Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.
Baser ME; Poussaint TY
J Med Genet; 2006 Mar; 43(3):285-7. PubMed ID: 15980114
[TBL] [Abstract][Full Text] [Related]
36. Expression of ErbB-1 and ErbB-2 in meningioma.
Wickremesekera A; Hovens CM; Kaye AH
J Clin Neurosci; 2010 Sep; 17(9):1155-8. PubMed ID: 20547458
[TBL] [Abstract][Full Text] [Related]
37. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
[TBL] [Abstract][Full Text] [Related]
39. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
